In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From SMC Ltd.

Tech Transfer Roundup: Oncology Deals Focus On CAR-T Innovations, ADCs, DNA Damage Response

Cancer deals involve City of Hope/Chimeric, CARISMA/NYU, Sorrento/Mayo Clinic, Rain/Drexel, Diaprost/Memorial Sloan Kettering, Alkido/University of Kentucky. Plus, research collaborations in brief.

Tech Transfer Round-Up Deals

Australian biotech boosted by Aus$200m VC fund

Brandon Capital, an Australian venture capital firm, has closed its third Medical Research Commercialisation Fund (MRCF), raising Aus$200m (around US$155m) and marking the country's largest ever life sciences-focused VC fundraising.


FDA's Woodcock: I'm not going anywhere

Dr Janet Woodcock wants to get one thing straight: She's not going anywhere.

US Capitol Capsule: Lawmakers voice concerns over Trans-Pacific Partnership

US state lawmakers last week joined a growing chorus, which also includes some members of Congress, calling for transparency and a cautious approach in the ongoing highly secretive negotiations for the Trans-Pacific Partnership (TPP) free-trade agreement with Australia, Brunei, Chile, Malaysia, New Zealand, Peru, Singapore, Vietnam, Canada and Mexico, with the 13th round of the pact's talks, which began on 2 July, concluding on 10 July in San Diego.

Neurology United States
See All

Company Information

  • Industry
  • Medical Devices
  • Services
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Large Molecule
  • Other Names / Subsidiaries
    • Oval Medical Technologies